Move from strain to strength. Reinvent your organisation for what patients need next.
Malaysia's healthcare industry is being redefined by various external forces—from persistent workforce shortages and health equity gaps to rising costs of care—compounded by an ageing population and the rapid rise in non- communicable diseases (NCDs). The bar for trusted healthcare has never been higher, catalysed by advanced technologies like artificial intelligence (AI), data analytics, and telemedicine, which are enabling more personalised, predictive, and preventive treatments when and where patients need them most.
Thriving in this dynamic ecosystem requires collaborative, cross-functional approaches that balance innovation with human-centred care.
Sustainable healthcare transformation is a journey which requires bold ideas, diligent execution, and an unwavering focus on patients.
We combine deep local insight with a global network of cross-sector expertise including technology and digital health, data analytics, deals strategy, finance, and public policy.
Our team works across Malaysia’s healthcare ecosystem, bridging public and private sectors, to design solutions that are both innovative and practical. We leverage data-driven insights and advanced digital tools to help healthcare providers improve patient outcomes and efficiency, while ensuring that transformations are fully aligned with Malaysia’s healthcare standards and regulations.
Partnership and co-creation are the key differentiators to our approach, helping you realise value where it matters.
We were appointed by the Malaysian government to augment the overall National COVID-19 Immunisation Programme management effort. We worked alongside the Malaysian cross-ministry COVID-19 Immunisation Task Force (CITF) led by the Ministry of Science, Technology and Innovation (MOSTI) with cooperation from the Ministry of Health.
The government wanted to ensure that vaccines were provided to everyone living in Malaysia in an efficient and equitable manner. This was critical in easing restrictions for individuals and businesses for the revival of the economy.
We supported the National COVID‑19 Immunisation Programme through the following activities:
Conducted readiness assessments across the vaccines‑to‑vaccinations roadmap for critical workstreams
Augmented the CITF Programme Management Office (PMO) to drive day‑to‑day coordination, accountability, and implementation across the programme
Supported the planning and set‑up of vaccination centres, including high‑capacity mega vaccination centres
Formulated and monitored national and state‑level vaccination targets and key performance indicators (KPIs)
Monitored appointment management processes and public support channels
Provided supply‑demand‑utilisation optimisation analytics and monitoring support
Performed risk assessments, programme assurance, and reporting
We performed a synergy assessment on the potential revenue and cost upsides, to support the valuation of a potential acquisition of a regional group of hospitals.
Our client was exploring a potential acquisition of a regional healthcare group with operations across Southeast Asia.
We were engaged to undertake a synergy assessment for the acquisition, to help the client assess the potential future value of the investment. The synergy analysis focused on the potential revenue and cost synergies from the acquisition—benchmarked against industry players.
Developed a synergy assessment model to estimate the potential revenue uplift from increased patient referrals across the broader healthcare group
Identified and quantified cost savings from the vendor consolidation as well as the headcount rationalisation exercise post-acquisition
Benchmarked the potential combined entity against best-in-class healthcare service providers to estimate the cost optimisation potential of the combined hospitals in the network
Based on our estimated financial impact of synergies from integrating hospital operations across both groups, we developed an illustrative value bridge, highlighting the revenue and cost synergy potential from the acquisition
Identified the key enablers, risks, and mitigating factors involved in achieving the proposed synergies
We were engaged to conduct commercial due diligence on an employee benefits Software as a Service (SaaS) platform in Malaysia, as part of a broader integrated due diligence service that included financial and tax due diligence.
Our client needed an in-depth understanding of the market potential and competitive landscape in Malaysia, Singapore, Vietnam, and Thailand, to identify potential growth opportunities.
In-depth assessment of the employee healthcare benefits market, including major trends and whitespace opportunities
Benchmarking of key competitors to establish the target’s competitive advantage
Conducted a survey on the target’s key customers to understand overall customer experience
Assessed the target’s business model, financial performance, and growth initiatives
Combined insights from the commercial, financial, and tax due diligence, to develop a holistic investment thesis
Identified specific value levers to support the platform's future growth and pathway to profitability
Identified key deal considerations, including key risk factors, which may impact the platform's potential pathway to profitability
We were engaged to support a leading pharmaceutical company to develop a strategic business plan—this included a strategic review of their existing operations and the development of a 5-year value creation and transformation plan.
Our client, a large integrated pharmaceutical player in ASEAN, was seeking to expand regionally. They needed advisory services to develop a 5-year value creation strategy and transformation plan for their business.
Review of the healthcare and pharmaceutical industry, including key market trends, opportunities, and the competitive landscape
Analysis of the profit pools along the pharmaceutical value chain
Baseline analysis of management’s business plan to evaluate opportunities for upside growth
Developed a detailed 5-year transformation strategy and value creation plan, premised on findings from the market and baseline analysis
Developed a robust 5-year value creation strategy and transformation plan, which included:
Value proposition to support differentiated market positioning
Product and market expansion opportunities
Target operating model, key target segments, and routes to market
Key operational levers for greater cost optimisation
Implementation roadmap and transformation strategy
Strategic implementation plan and robust programme management framework